RecruitingNCT00579566

Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma

Sponsor

Memorial Sloan Kettering Cancer Center

Enrollment

3,000 participants

Start Date

Jun 1, 2002

Study Type

OBSERVATIONAL

Conditions

Sarcoma

Summary

The purpose of this study is to study normal and sarcoma cells. To study these cells we need to have human tissue. You will be having or have already had a procedure to remove tissue. We would like to use some of this tissue. We will use it for laboratory studies on the diagnosis,behavior and treatment of sarcoma. We will perform an extensive analysis of your samples. We will only use extra tissue left over after all needed testing has been done or remove an additional small amount of tissue if you are having a biopsy. We will also take blood samples before and/or after your procedure to measure biochemical factors that may help us predict the behavior of sarcoma.

Eligibility

Plain Language Summary

Simplified for easier understanding

This study is searching for new biological and molecular markers in blood and tumor tissue from patients with soft tissue sarcoma (a rare cancer of muscles, fat, nerves, or connective tissue) to improve diagnosis and prediction of how the cancer will behave. **You may be eligible if...** - You have been diagnosed with a soft tissue sarcoma - You are scheduled for surgery or biopsy where additional tissue samples can be collected - You are willing to provide blood samples before, during, and after treatment **You may NOT be eligible if...** - You have not been diagnosed with a soft tissue sarcoma - You are unable to provide informed consent - Your general health makes participation unsafe Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.